BioCentury
ARTICLE | Politics, Policy & Law

Marks takes over FDA vaccines office

Move sparks departures of two vaccine reviewers

September 27, 2021 9:34 PM UTC

In a sign of the continuing turbulence in FDA’s regulation of COVID-19 vaccines, Peter Marks, director of FDA’s Center for Biologics Evaluation and Research, announced Monday that he has taken over responsibility for the Office of Vaccines Research & Review.

The move came a month before the resignation of its director, Marion Gruber, became effective. Phil Krause, deputy director of OVRR has also announced his resignation, effective in November...